Renaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO ETF (NYSE: IPO) and the Renaissance ...

Over the past couple weeks, as we’ve seen Klarna, StubHub and others delay scheduled pre-IPO roadshows, it appears markets ...

According to Renaissance Capital, a leading provider of pre-IPO research and IPO-focused ETFs, there have been 56 IPOs priced so far in 2025, through April 4, up 70% over Q1 2024. Of those ...

Dreamland Limited (TDIC) has filed to raise $9 million in an IPO of its Class A ordinary shares ... According to a 2025 market research report by Grand View Research, the Chinese MICE (Meetings ...

CEO of IPO research firm IPOX, said. The Magnificent Seven - a group of tech giants that have driven much of the stock market's gains in recent years - have been battered so far in 2025.

UK biotech Achilles Therapeutics has completed its initial public offering (IPO) in the US ... was formed in 2016 as a spin-out of Cancer Research UK to develop T cell therapies directed against ...